IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Alkem Laboratories IPO listing price is ₹ 1381.45, issue price is [●], and currently trading at ₹ 5098.50 as on May 30, 2025. Alkem Laboratories IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Alkem Laboratories IPO is a Book Building listing on BSE,NSE exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , Edelweiss Financial Services , J.P. Morgan India , Nomura Financial Advisory And Securities (India) are the merchant bankers of Alkem Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Alkem Laboratories IPO offer price is ₹ 1050.00 and got listed at ₹ 1381.45. Read Alkem Laboratories IPO details mentioned above.The IPO of Alkem Laboratories Limited was listed on 23rd December 2015. As of today, Alkem Laboratories IPO is trading at ₹ 5098.50, compared to the previous day’s close of ₹ 5294.50. Read the report above for detailed IPO performance.
The issue price of Alkem Laboratories IPO was [●] per equity share.
Alkem Laboratories IPO was listed at ₹1381.45 on the stock exchange on 23rd December 2015. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Alkem Laboratories IPO is ₹ 5098.50.
The 52-week high for Alkem Laboratories IPO is ₹ 6439.90, while the 52-week low is ₹ 4407.05. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Alkem Laboratories IPO listed at ₹ 1381.45 against the issue price of [●] per equity share, showing a listing day gain/loss of 331.45 (31.57%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Alkem Laboratories IPO stock moved from its listing price of ₹ 1381.45 to the current price of ₹5098.50 per equity share, reflecting a change of 269.07% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Alkem Laboratories IPO issue date of May 30, 2025 and CMP of ₹5098.50, the estimated CAGR is approximately 18.21%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
[●]
Listing Price :
₹ 1381.45
Previous Day Closing
₹ 5294.50
Alkem Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Alkem Laboratories Financial Review Page
Merchant Banker(s) of Alkem Laboratories IPO: Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited
Alkem Laboratories IPO subscription was 44.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Alkem Laboratories IPO listed at a listing price of 1381.45 against the offer price of 1050.00.
The current market price of Alkem Laboratories is 5098.50.
Why Us?
